HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Coming up short: Low supplies of key drugs force physicians to scramble
-
- CLL linked to poorer survival in those with malignant melanoma, MCC
- Dual, triple antiplatelet regimens equal for prevention of blood clots after angioplasty
- Molecule helps control severity of GVHD
- Number of county-wide dermatologists associated with lower mortality rates for melanoma
- Palliative care screenings identified more patients for referral
- Protein expression suppressed spread of urothelial cancer to lungs
- Radionuclide therapy may be linked to hematologic consequences in neuroendocrine tumors
- REDUCE: Coronary artery disease potential risk factor for prostate cancer
-
- STAT3 gene mutation in NSCLC independent of typical oncogenic driver mutations
- Study identified source of crizotinib resistance in ALK-positive lung cancer
- Targeted education may ensure early integration of palliative care
- TRA 2P–TIMI 50: Vorapaxar reduced CV death, ischemic events
- A 60-year-old female with smoking history presents with a right upper lobe lung nodule Ramya Varadarajan, MD
- ODAC rejects ridaforolimus as maintenance therapy for sarcoma
- ODAC supports approval of sarcoma drug
- Renal cell carcinoma: A correlation of radiological and pathological findings Munir Ghesani, MD, FACNM; Peerapod Chiowanich, MD; Matthew Teng, MD; Darren Buonocore, MD; Sumit Talwar, MD
-